C4 Therapeutics Inc (CCCC) has gained Thursday morning, with the stock gaining 4.38% in pre-market trading to 11.43. CCCC's short-term technical score of 85 indicates that the stock has traded more bullishly over the last month than 85% of stocks on the market. In the Biotechnology industry, which ranks 95 out of 146 industries, CCCC ranks higher than 86% of stocks. C4 Therapeutics Inc has risen 72.99% over the past month, closing at $5.78 on February 1. During this period of time, the stock fell as low as $5.30 and as high as $10.25. CCCC has an average analyst recommendation of Strong Buy. The company has an average price target of $15.90.
News Home
C4 Therapeutics Inc has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Biotechnology industry which is number 47 by this metric, CCCC ranks better than 47% of stocks.
Should You Sell C4 Therapeutics Inc (CCCC) Stock Thursday Morning?
Mentioned in this article
CCCC has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on CCCC!